The most prevalent reasons for exclusion included heparin infusion for less than 24 hours and inadequate protocol compliance. Inadequate protocol compliance was the reason for exclusion in 13 of ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

While in the ED, the patient was started on nitroglycerin infusion to control chest pain, aspirin 325 mg orally once daily, metoprolol tartrate 50 mg orally every 12 hours, and heparin infusion ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

After hours: February 3 at 4:06:48 PM EST ...

The central nervous system (CNS), composed of the brain, spinal cord, and retina, has a limited capacity to spontaneously regenerate and this, coupled with few regenerative strategies available ...

Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining ...

(b) Bioactive pumps, able to control on-demand the continuous release of AMPs in the site of infection. (c) Watchtowers, able to release specific combinations of AMPs depending on the stimulus.

The term dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders that are characterized by ventricular dilation and depressed myocardial performance in the absence of ...

Finally, a problem of major relevance to samples taken during AMI or in other hospitalised patients is that heparin has been shown to be a significant inhibitor of PCR-based reactions (a crucial ...

Background Physicians treating acute pulmonary embolism (PE) are faced with difficult management decisions while specific guidance from recent guidelines may be absent. Methods Fourteen clinical ...